AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Dr. Thomas Safreed, a renowned cancer researcher, introduced a groundbreaking approach to cancer as a metabolic disease. His protocol, including metabolic therapies like caloric restriction, fasting, and a ketogenic diet, has shown promising results in slowing down and even reversing tumor growth in mice. Despite the experimental nature of the protocol, organizations like the Hippocrates Research Foundation are documenting case studies to raise awareness and interest in this novel therapeutic strategy.
Den Stacy, diagnosed with stage four pulmonary artery sarcoma, chose to deviate from traditional chemotherapy and radiation treatments. Opting for Dr. Safreed's metabolic therapies with support from the Hippocrates Research Foundation team, Den constructed a personalized press-pulse protocol inspired by Safreed's research. Remarkably, subsequent PET-CT scans revealed no traces of cancer, showcasing the effectiveness of this alternative approach.
The Hippocrates Research Foundation emphasizes a preventative and holistic outlook towards cancer management, focusing on repairing damaged mitochondria from the onset of treatment. By monitoring circulating cancer stem cells and DNA fragments through advanced testing methods, they strive to lower cancer recurrence risks and improve long-term outcomes for patients. Their individualized and non-toxic approach aims to enhance overall health and performance.
Metabolic therapies and tailored prevention strategies form the core of the Hippocrates Research Foundation's cancer care approach. By shifting the focus from mutation-centric treatments to targeting mitochondrial dysfunction and optimizing cellular environments, they aim to address cancer at its metabolic root. Emphasis on lifestyle modifications, advanced diagnostics, and whole-body health improvement underscores their commitment to providing effective and low-risk solutions for cancer patients.
The podcast episode delves into the rigorous process of implementing the Press Pulse Protocol, highlighting the intricacies involved in inhibiting glucose and glutamine as primary cancer fuel sources. Through meticulous monitoring of fat, protein, and carb grams, coupled with twice-daily glucose measurement, the protocol aims at achieving a therapeutic glucose range of 55 to 65 milligrams per deciliter, emphasizing the need for precise control and consistency for metabolism effects.
The discussion underscores the significant level of precision and individual compliance required for the Press Pulse Protocol, emphasizing a meticulous approach to self-administration and execution of protocol requirements. The engagement necessitates a consistent focus on specific macro and micro nutrient intake, along with regular blood glucose and ketone monitoring, fostering a detailed understanding and application of the protocol's fundamentals.
The importance of a comprehensive team collaboration in cancer management is highlighted, featuring functional medicine doctors and clinics worldwide that support and guide individuals in following the Press Pulse Protocol. The team composition typically includes concierge doctors and oncology experts who work synergistically to provide personalized guidance, address metabolic therapies, and oversee treatment adherence.
Insights into liquid biopsy as a tool for cancer surveillance and early detection are discussed. Liquid biopsies offer a non-invasive approach to monitor circulating cancer cells and potential recurrence, indicating a preventative utility in detecting cancer progression at early stages. The integration of liquid biopsies into cancer monitoring strategies enhances surveillance precision and enables proactive management.
The podcast narrates the journey of achieving No Evidence of Disease (NED) status through the Press Pulse Protocol, showcasing a case study of successful cancer management. The narrative unfolds the challenges and triumphs in pursuing precision medicine, implementing metabolic therapies, and sustaining vigilant adherence to the protocol requirements, leading to a remarkable outcome of eliminating visible tumors and advancing towards optimal health.
The personal account of navigating cancer treatments intertwines with the exploration of alternative cancer management approaches, shedding light on the journey towards remission and recovery. The narrative encapsulates the transformational impact of precision medicine and metabolic therapies on combating cancer, underscoring the critical role of diligence, teamwork, and innovative surveillance strategies in achieving positive outcomes and holistic well-being.
Protecting and improving mitochondrial function is crucial for preventing cancer. Various factors like overconsumption of fructose, alcohol, high carbohydrate diets, and lack of resistance training can damage mitochondria, increasing cancer risk. Simple lifestyle changes like cold water exposure, hyperbaric oxygen therapy, and phospholipid supplements can help enhance mitochondrial health and reduce cancer risk.
Regular cancer screening tests like the Grail test can detect cancer early, even before visible symptoms appear. These tests, conducted annually or biennially, can provide insights into circulating cancer stem cells and other indicators. Early detection allows for proactive management and intervention, significantly improving outcomes and potentially preventing clinical disease.
Understanding the metabolic nature of cancer is essential for making informed decisions regarding diagnosis and treatment. Educating oneself about metabolic therapies, mitochondrial health, and available options can empower individuals to ask relevant questions, evaluate treatment approaches, and navigate the complex landscape of cancer care. Seeking reputable sources of information and expert guidance can help individuals make well-informed choices for managing cancer effectively.
This interview is for informational purposes and should not be used in place of an actual doctor's visit. Always work with your healthcare provider before making significant changes to your health or medical treatment plan.
This episode is brought to you by Bioptimizers and Lumebox.
Dr. Thomas Seyfried's groundbreaking research approaches cancer as a metabolic dysfunction and addresses its root cause. Although controversial, this approach has provided hope for practitioners and cancer patients.
Today on The Dhru Purohit Podcast, Dhru sits down with Den Stacey, who, after being diagnosed with Stage 4 cancer, embarked on a journey seeking guidance from the Hippocrates Research Foundation and ultimately became cancer-free. The HRF Team of Daniel Orrego, Dr. Gregory Howard, and Dr. Michelle Howard describe their research and approach to guiding those diagnosed with cancer, including implementing a protocol that starves the cancer and fuels the body.
In this episode, Dhru and the guests dive into (audio version / Apple Subscriber version):
Also mentioned in this episode:
Go to bioptimizers.com/dhru now and enter promo code DHRU10 to get 10% off any order and up to 2 travel-size bottles of Magnesium Breakthrough for a limited time.
Lumebox is offering my community $260 off their FDA-approved portable Red Light device! That's over 50% off! Go to thelumebox.com/dhru and get your Red Light device.
Hosted on Acast. See acast.com/privacy for more information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode